A zymogen is a precursor of an enzyme that becomes substantially more active after a chemical activation step, commonly limited proteolysis. Regulating activation permits a biological cell or organism to produce a catalytic precursor before the full activity is needed. Low precursor activity need not be exactly zero in every assay.
Prothrombin provides a concrete example. Specific cleavage sites connect its precursor architecture to generation of thrombin. A 2013 structural study examined an engineered precursor lacking one domain and carrying an inactive catalytic-site substitution, supplemented by solution measurements. It related exposure of activation sites to conformational organization.[ref]
Crystal Structure of Prothrombin Reveals Conformational Flexibility and Mechanism of Activation by Nicola Pozzi and others. Abstract and Fig.1: precursor construct, cleavage sites and structural interpretation
A zymogen can therefore be a folded, regulated protein rather than an unfinished chain awaiting protein folding.Consider a synthetic assay in which 20 percent of a precursor pool becomes active enzyme, one molecule for one molecule. Active enzyme is then . At saturating substrate and an illustrative turnover number of , the predicted initial reaction rate is . Measuring total precursor-plus-product abundance would not reveal that active fraction.
Articles by others on the same topic
There are currently no matching articles.